Loading the SOTA2 catalog…
OI Suite
A SaaS enterprise solution for AI-driven oncology research, including hypothesis generation, biomarker discovery, response prediction, and model training with limited data.
What is OI Suite?
A SaaS enterprise solution for AI-driven oncology research, including hypothesis generation, biomarker discovery, response prediction, and model training with limited data. At its core is the Oncology Intelligence Foundation Model (CanvOI), a scalable, generalizable, and versatile backbone for diverse oncology applications.
Product typeDrug Discovery & Biotech
Pricing · Subscription
DeploymentOn-premises
APINot available
What teams use OI Suite for
AI-driven hypothesis generation for oncology research
Biomarker discovery
Drug development and clinical trial acceleration
Response prediction and prognosis assessment
Pathological feature identification with limited data
Integrations and access
Platforms, integrations, and language support vary by plan and region. Confirm final requirements with the vendor.
Platforms
IntegrationsAPI and webhooks
Languages
Support
What reviewers say
Community reviewsReviews are owned and editable by their authors.
Sign in to reviewLoading community reviews…
Enterprise readiness
Compliance claims are normalized from current vendor documentation and independently reviewed by SOTA2.
Data retention:
Benchmarks and comparisons
Independent benchmarksStructured task results are being verified.
Side-by-side comparisonsComparison workspaces will be available in a later release.
